Our study supplemented understanding on the role of RIPK2 in PC, indicating that the expression of RIPK2 was aberrantly increased in PC and a higher expression of RIPK2 predicted a poorer prognosis of PC patients. Here, RIPK2 is linked to pachyonychia congenita.